RecruitingNCT07042672
Behavioral therapy and GLP-1 medicine for binge eating
About this title
Read the official source — NCT07042672Observational studyAges 18–65NorwayEating disorders
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- BergenSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 1, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 80
- Sponsor
- Haukeland University Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Not clearly listed
- Locations
- Norway
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07042672
- Official title
Show the full official title
Behavioral Therapy With and Without GLP-1 Analogue in Patients With Morbid Obesity and Binge Eating Disorder: A Clinical Prospective Observational Study on Body Weight, Binge Eating Behavior, and Harmful Coping Strategies
Recruitment & locations
RecruitingBergen
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Haukeland University Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including GLP-1.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
